⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IONS News
Ionis Pharmaceuticals, Inc. Common Stock
Ionis announces zilganersen New Drug Application for Alexander disease (AxD) accepted by FDA for Priority Review
businesswire.com
IONS
n-Lorem Publishes Commentary Offering Insight into Potential Commercialization Strategies for Nano-rare Medicines
businesswire.com
IONS
National Triglyceride Alliance Celebrates One Year of Impact and Recognizes National Triglycerides Day
prnewswire.com
IONS
ARWR
AMRN
Kardigan Announces Multiple Presentations at ACC.26 from its Late-Stage Portfolio of Personalized Cardiovascular Medicines
businesswire.com
IONS
SNY
BMY
Dallas Drive Leaps to Their First Win of the 2026 Pro Cheer League Season
prnewswire.com
IONS
Form 8-K
sec.gov
IONS
Ionis announces changes to Board of Directors
businesswire.com
IONS
Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences
globenewswire.com
IONS
BIIB
Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight
prnewswire.com
BIIB
IONS
ALNY
AZN
GILD
JNJ
BMRN
VRTX
ASTL
PFE
NVO
REGN
Oligonucleotides Global Markets, 2022-2024 & 2025-2030, Profiles of Major Players - Alnylam Pharmaceuticals, Biogen/Ionis Pharmaceuticals, Novartis, and Sarepta Therapeutics
globenewswire.com
ALNY
SRPT
IONS
JAZZ